Lantheus Holdings (LNTH) Other Operating Expenses (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Other Operating Expenses came in at $59.3 million in Q1 2026, up 2645.4% on a QoQ basis from $2.2 million in Q4 2024.

Lantheus Holdings (LNTH) Other Operating Expenses (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 6 years of Other Operating Expenses data on file, last reported at $59.3 million in Q1 2026.

  • On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $59.3 million in Q1 2026; TTM through Mar 2026 was $59.3 million, a 2645.4% increase from a year earlier, with the FY2024 full-year figure at $8.4 million, changed N/A from the prior year.
  • Other Operating Expenses for Q1 2026 stood at $59.3 million, up from $2.2 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for LNTH reached as high as $59.3 million in Q1 2026 and fell as low as $2.2 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 59.33 Mn
Dec 31, 2024 2.16 Mn
Mar 31, 2024 6.25 Mn
Mar 31, 2021 15.26 Mn
Dec 31, 2016 -120,000.00
Sep 30, 2016 560,000.00
Jun 30, 2016 117,000.00
Mar 31, 2016 5.83 Mn
Dec 31, 2015 -12.58 Mn
Sep 30, 2015 2.46 Mn
Jun 30, 2015 2.64 Mn
Mar 31, 2015 6.20 Mn
Dec 31, 2014 4.72 Mn
Sep 30, 2014 3.05 Mn
Jun 30, 2014 2.69 Mn